Basel, 06 February 2019 Roche joins the World Federation of Hemophilia Humanitarian Aid Program Hemlibra donation will provide prophylactic treatment to as many as 1,000 people with haemophilia A over five years in countries where there is little or no access to haemophilia treatment Donation will substantially increase the number of people receiving prophylactic treatment... Read more
Madison, WI USA. (February 5, 2019) Promega Corporation today announced FALCO biosystems of Kyoto, Japan, a core business company of FALCO HOLDINGS, working in collaboration with Promega microsatellite instability (MSI) chemistry and assay design, obtained companion diagnostic approval for FALCO’s MSI-IVD from Japan’s regulatory agency, the Ministry of Health, Labour and Welfare (MHLW). The MSI-IVD Kit (FALCO),... Read more
FEBRUARY 26, 2019 MINNEAPOLIS, Feb. 26, 2019 /PRNewswire/ — Bio-Techne has entered into a strategic cooperation agreement in the precision medicine field with Lisen Imprinting Diagnostics Wuxi Co., Ltd, China. Liwen Pei, Managing Director of Bio-Techne China, and Ning Zhou, CEO of Lisen, attended the meeting and signing ceremony. Bio-Techne is a leading provider of high-quality... Read more
Burlington, Massachusetts, February 4, 2019 — MilliporeSigma today announced the winners of its Advance Biotech Grantprogram in Europe. The grant is given to small- and mid-size biotechnology companies that need funding and expertise to get their therapies to market. Applicants from emerging biotech companies across Europe were asked to describe their projects, the medical needs they solve,... Read more
Dubai, UAE; January 29, 2019: On the sidelines of Arab Health 2019, the region’s leading healthcare exhibition, GE Healthcare and The Aga Khan University Hospital (AKUH) in Karachi, Pakistan, today announced a strategic partnership to give Pakistan’s leading private quaternary care hospital access to a new range of advanced medical imaging and diagnostic equipment. GE... Read more
Basel, 30 January 2019 Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer’s disease (AD) – other company programmes in AD continue The Alzheimer’s Prevention Initiative (API) study of crenezumab in familial Alzheimer’s disease continues Roche remains committed to ongoing clinical studies in Alzheimer’s disease, including GRADUATE Phase... Read more
WALTHAM, Mass., Jan. 28, 2019 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has signed a definitive agreement to sell its Anatomical Pathology business to PHC Holdings Corporation, a global innovator in healthcare solutions, for approximately $1.14 billion in cash. The Anatomical Pathology business is a... Read more
Powerful Single Cell Bioinformatics Solution in a Graphical User Interface Powerful Single Cell Bioinformatics Solution in a Graphical User Interface ST. LOUIS & CAMBRIDGE, Mass.–(BUSINESS WIRE)–1CellBio Inc. and Partek Incorporated have partnered to deliver a data analysis pipeline for the inDrop™ System for use within Partek® Flow® bioinformatics software. The pipeline allows users to pre-process raw inDrop single cell RNA-Seq data and utilize... Read more
MINNEAPOLIS, Jan. 24, 2019 /PRNewswire/ — Bio-Techne announces the launch of their cell and gene therapy portfolio. As a leading manufacturer of GMP-grade ancillary materials and automated instrumentation, Bio-Techne is uniquely able to offer solutions that advance the translation of cell and gene therapies, from discovery-level research to the optimization of cell therapy manufacturing unit... Read more
Shimadzu Corporation has announced plans to build the SHIMADZU Future Collaboratory at the Technology Research Laboratory in Keihanna Science City, Kyoto Prefecture, Japan to expand the program of innovation at Shimadzu Corporation. The new laboratory will further drive research and development by focusing on several core themes including artificial intelligence (AI), innovative biotechnology, brain-science and... Read more